Comparing the benefits of applying a vacuum assisted lancing device in reducing lancing pain, improving self-monitoring frequency and reducing HbA1c in people with diabetes

Kesavadev, Jothydev; Chandran, Gopika Beena; Basanth, Anjana; Krishnan, Gopika; Shankar, Arun; Jothydev, Sunitha

doi:10.1016/j.dsx.2023.102731

Cited by 2 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…В настоящее время разработаны усовершенствованные вакуумные прокалыватели, например, Genteel (США). В сравнении с обычными не вакуумными устройствами уменьшается болевой эффект, повышается частота самоконтроля, благодаря чему снижается уровень HbA 1c [32]. В рандомизированном одиночном слепом одноцентровом исследовании отмечалась тенденция к увеличению объема капли крови и выраженности боли с увеличением глубины прокола и диаметра ланцета [33].…”

Section: электрохимические глюкометрыunclassified

Evolution of blood glucose self-monitoring technology

Suplotova,

Alieva

2023

Diabetes mellitus

View full text Add to dashboard Cite

In 1838 G. Rees, a doctor from London (Guy's Hospital), for the first time isolated excess sugar from the blood serum of a patient with diabetes mellitus. Diagnosis of diabetes mellitus gradually developed. The next step was the understanding that regular monitoring of glucose levels by the patient himself is an integral part of diabetes mellitus therapy. The starting point of the technology for self-monitoring of diabetes mellitus was the determination of the sugar content in urine using chemical reactions. The method had no great clinical significance, it only indicated a progressive disease. The first Dextrostix blood glucose test strip (Ames-Mile's laboratories) was introduced in 1964. In 1970, the first automated blood glucose analysis system, the Ames Reflectance Meter (ARM), was created. Over time, the technology has been improved, accuracy, visibility, comfort, and an individual approach to glucometry have been formed. A new chapter was the development of remote technologies and the possibility of remote monitoring. More advanced data processing is now available in tabular and graphical form, with the calculation of 7-, 14-, 30-, and 90-day average glycemic values. A promising direction is the introduction of artificial intelligence in the management of diabetes mellitus.

show abstract

Section: электрохимические глюкометрыunclassified

Evolution of blood glucose self-monitoring technology

Suplotova,

Alieva

2023

Diabetes mellitus

View full text Add to dashboard Cite

show abstract

Comparing Points in Target Range Assessed by Blood Glucose Monitoring Using a Vacuum-based Lancing Device and Conventional Lancing Devices

Kesavadev,

Shankar,

Basanth

et al. 2022

International Journal of Diabetes and Technology

View full text Add to dashboard Cite

Background: Time-in-range, the recently introduced metric is effective with CGM devices. Several reasons such as inaccessibility, out-of-pocket expense etc. challenge the wider acceptance of CGM devices globally. In this scenario a similar metric termed point-in-range (PIR) was introduced which can be calculated based on the frequent readings from blood glucose meters. Aim: The current study aims to compare the points in range in people with type 1 diabetes and type 2 diabetes using Genteel, a commercially available lancer that applies vacuum after lancing and a non-vacuum conventional lancing device. Methods: Data for the study was retrieved from an open-label, 24-week cross-over trial and analyzed retrospectively. The cohort included both patients with type 1 diabetes (n=58; age= 17.70 ± 10.18) and type 2 diabetes. The participants used Genteel for 12 weeks and then switched to a conventional lancing device for additional 12 weeks or vice versa. PIR was calculated and compared when using a Genteel and using a conventional lancer. Statistical analysis was carried out using SPSS software, version 16, and a significance threshold of P<0.05 was used. Results: Selected individuals with T1D, showed significantly higher frequency of blood glucose level falling within the range and significantly lower frequency of blood glucose level falling above range (PAR) while using Genteel in comparison to the conventional lancing devices. In addition, a significant reduction in HbA1c levels (from 8.94 ± 1.77% to 8.25 ± 1.67%) was observed among the subjects with T1D who used the Genteel device. No change in the frequency of blood glucose level falling within the range was observed in patients with type 2 diabetes. Conclusion: Painless glucose monitoring facilitated by Genteel may have contributed to the increased monitoring frequency which in turn contributed to higher PIR, lower PAR and significant reduction in the HbA1c.

show abstract

Comparing the benefits of applying a vacuum assisted lancing device in reducing lancing pain, improving self-monitoring frequency and reducing HbA1c in people with diabetes

Cited by 2 publications

References 24 publications

Evolution of blood glucose self-monitoring technology

Evolution of blood glucose self-monitoring technology

Comparing Points in Target Range Assessed by Blood Glucose Monitoring Using a Vacuum-based Lancing Device and Conventional Lancing Devices

Contact Info

Product

Resources

About